Stenocare has been an active participant in the European medical cannabis industry since it was founded in 2017. The company has entered six different countries with prescription-based medical cannabis products and has been an active participant in developing these markets.

Now, Stenocare has been nominated and shortlisted in the annual industry awards as one of the best European Cannabis Companies of the Year. The European industry has hundreds of companies across the entire medical cannabis value chain, and a total of seven companies have been shortlisted for the prestigious award "European Cannabis Company of the Year".

The Business of Cannabis Awards are dedicated to honouring excellence in various facets of the cannabis sector, showcasing innovations, leadership, and growth within this dynamic industry. This year's event promises to be a remarkable gathering of industry leaders, innovators, and influencers.

Comment from CEO, Thomas Skovlund Schnegelsberg: "We are both honoured and humbled by the recognition of being one of the best medical cannabis companies in Europe. We have a strategy of becoming a leading European brand within medical cannabis, and being shortlisted with a group of highly professional peers shows that we are on the right path toward that ambition."

The winner of "European Cannabis Company of the Year" will be announced during the annual industry conference "Cannabis Europa" in London on June 25.